-
  • Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma.

    1 januari 1970 | Pubmed | whoisjjc_k77083ou
  • Related Articles

    Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma.

    Mol Carcinog. 2019 Aug 29;:

    Authors: Pang L, Xu L, Yuan C, Li X, Zhang X, Wang W, Guo X, Ouyang Y, Qiao L, Wang Z, Liu K

    Abstract
    Sorafenib is the standard first-line systemic chemotherapeutic drugs for advanced hepatocellular Lees meer

    Source:: Pubmed